Pilulka
Online pharmacy with more than 1442 sampling points across the Czech Republic.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Acquisition | |
| Total Funding | 000k | ||
| EUR | 2017 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 34 % | 3 % | (13 %) | (39 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | - | (4 %) | (3 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (1 %) | (1 %) | (3 %) | (8 %) | (10 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Pilulka Lékárny a.s. is a technology-driven company operating in the Central European pharmacy market. Founded in 2013 by brothers Petr and Martin Kasa, the company leverages their extensive e-commerce background, which began in the late 1990s with the creation of Kasa.cz, one of the largest e-shops of its time. After selling their initial venture, the Kasa brothers identified an opportunity within the fragmented and traditional healthcare sector, leading to the establishment of Pilulka.
The company's business model integrates online and offline channels, comprising a network of over 150 brick-and-mortar pharmacies in the Czech Republic and Slovakia, alongside a robust e-commerce platform. This hybrid approach allows Pilulka to serve a broad customer base, offering a wide range of products that extends beyond pharmaceuticals to include health supplements, mother and baby care, specialized foods, and sports nutrition, totaling over 35,000 items. Revenue is generated through both online sales and transactions in their physical pharmacy locations. The company's strategy focuses on consolidating the market by combining various health-related segments into a single, customer-centric platform.
A significant milestone in Pilulka's history was its successful Initial Public Offering (IPO) on the START Market of the Prague Stock Exchange in October 2020. The IPO was substantially oversubscribed, indicating strong investor confidence, and raised significant capital to fund further expansion and development. Following its founding, the company quickly expanded, entering the Slovakian market right after its start, Romania in 2018, and has since made inroads into Hungary and Austria. Pilulka has also developed its own logistics solution, Pilulka Auto, and a mobile application to enhance customer service. In 2021, the company launched Pilulka Lab, a joint venture with startup accelerator StartupYard, to invest in and mentor eHealth startups in the CEE region.
Keywords: online pharmacy, e-commerce, pharmaceutical retail, Central Europe, Prague Stock Exchange, healthcare technology, brick-and-mortar pharmacies, eHealth, prescription delivery, OTC drugs, health supplements, omnichannel retail, Czech Republic, Slovakia, Romania, Petr Kasa, Martin Kasa, IPO, pharmaceutical distribution, mobile pharmacy, healthcare services
